Patent · US Active

Nanoparticle contrast agents for diagnostic imaging

US8728529B2 · kind B2 · utility

3Cited by
2References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 29, 2008
Grant dateMay 20, 2014
Priority date
Expiry dateApr 13, 2031

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB82Y5/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions of nanoparticles functionalized with at least one zwitterionic moiety, methods for making a plurality of nanoparticles, and methods of their use as diagnostic agents are provided. The nanoparticles have characteristics that result in minimal retention of the particles in the body compared to other nanoparticles. The nanoparticle comprises a core, having a core surface essentially free of silica, and a shell attached to the core surface. The shell comprises at least one silane-functionalized zwitterionic moiety.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.